Literature DB >> 6220894

Beta blockade for dilated cardiomyopathy: the evidence against therapeutic benefit.

H Ikram, M A Fitzpatrick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6220894     DOI： 10.1093/eurheartj/4.suppl_a.179

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  3 in total

1.  The effect of beta-adrenergic blockade in dilated cardiomyopathy--a questionnaire study in Japan.

Authors:  A Matsumori; M Tominaga; S Handa; Y Fukuchi; A Kitabatake; H Matsuo; S Matsuo; J Mihune; T Nakano; S Nobuoka
Journal:  Heart Vessels Suppl       Date:  1991

Review 2.  Treatment of mild congestive heart failure. The potential for new drugs to reduce the risks.

Authors:  U Ravens; M Wehr
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

Review 3.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.